MSc Cancer Immunotherapy
- Country United Kingdom
- Course Duration 12 month
- Course Type Full Time
- Courses Campus On Campus
- Language Specification IELTS
- Program Level Post-Graduate
- Education Required Undergraduate
- Admission intake SEP
- Minimum GPA 3.2
Application Charges
| Application Fee | Tution Fee |
|---|---|
| Free | GBP 14,750 |
Application Date
| Application Start Date | Application Closing Date |
|---|---|
|
2023-02-01
|
2023-08-16
|
Program Description
The aim of the MSc in Cancer Immunotherapy is through an understanding of the numerous ways in which cancers and the immune system interact, to learn how cancer immunotherapies are developed. The utilisation of the immune system in cancer therapy has been a long standing goal in the field. The course will provide a thorough understanding of immune effector mechanisms and of cancer biology and the personal skills the students will develop, through problem-based learning and self-directed learning.Alternatively, consider taking our other MSc Cancer Immunotherapy routes:Why choose this course?
- You’ll be taught by our expert staff and innovative speakers from the biopharmaceutical industry
- Our modern Science Building provides excellent facilities for laboratory experiments, including DNA and genomic analysis eg QPCR, protein and proteomic science (eg MALDI-ToF), cell culture and Enzyme-based assays, isolated tissue studies and immunohistochemistry
- When you graduate, you’ll be equipped to work in a broad range of fields including medical or pharmaceutical research and development, clinical trials, public health and epidemiology, academia research, medical writing and science journalism, education, or patent law
- We adopt a blended learning approach to teaching, focussing on problem-based scenarios so you can develop strong critical analysis skills. You’ll benefit from exposure to practical techniques and guaranteed laboratory-based research projects.
What will I study?
You’ll benefit from the research interests of the Bioscience Research Group. These include studies of the tumour microenvironment and communication with infiltrating immune cells, the methods tumours employ to diminish the effectivity of immune effector mechanisms and how tumours communicate using extracellular vesicles with pre-metastatic sites. We’ll cover topics such as adoptive T cell therapy, tumour-associated macrophages, NK cells, monoclonal antibodies in cancer therapy, vaccines, microbial cancer therapies and immune checkpoint blockade.Teaching will be delivered through lectures, tutorials and practical classes. You’ll immerse yourself in a research project which utilises problem-based and self-directed learning. You’ll explore case studies to gain a strong critical understanding. Through your research projects, carried out in our innovative Science Building and supervised by world-leading researchers, you’ll be trained in data collection, analysis and its interpretation. You’ll also benefit from expert external speakers from the biopharmaceutical industry.Other Requirements
The normal entry requirements for the programme are: 65% or above average grade in an undergraduate degree in the Biological Sciences or A professional qualification accepted as equivalent to the above; or A qualification in veterinary science, medicine or dentistry; or A first or second class Honours Degree in disciplines other than those described above but where the applicant, in the opinion of the Programme Leader, would benefit from, and succeed on, the programme.Extra Notes
* NOTE : The Tuition Fee is subject to change Semester wise, as such for exact Tuition Fee kindly see the Website of the respective University.* NOTE : Pathways : Students who want to pursue a Graduate Degree through a particular University but are unable to meet the university requirements for the GPA, GRE/GMAT or English Language scores, have to take up an additional academic and language support i.e. pathways in order to ensure the admit and study at the desired University.
